User Tools

Site Tools

Trace: • glargine • complement_system
endocrine:sglt2:empagliflozin

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

endocrine:sglt2:empagliflozin [2026/02/13 00:08] – created andrew2393cnsendocrine:sglt2:empagliflozin [2026/02/13 00:08] (current) – [Empagliflozin vs Dapagliflozin] andrew2393cns
Line 120: Line 120:
 [[endocrine:sglt2:dapagliflozin|Dapagliflozin]]: [[endocrine:sglt2:dapagliflozin|Dapagliflozin]]:
  
-• Strong HF data (DAPA-HF) +  * • Strong HF data (DAPA-HF) 
-• Strong CKD data (DAPA-CKD)+  * • Strong CKD data (DAPA-CKD)
  
 Empagliflozin: Empagliflozin:
  
-• First to show CV mortality reduction +  * • First to show CV mortality reduction 
-• Similar HF and renal benefit+  * • Similar HF and renal benefit
  
 Clinically interchangeable in most HF patients. Clinically interchangeable in most HF patients.
endocrine/sglt2/empagliflozin.txt · Last modified: by andrew2393cns